Inhibikase Therapeutics Inc S-1

InhibikaseTherapeuticsInc_S-1_20230203-232058.png

Inhibikase Therapeutics Inc, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC S-1 filing on February 02, 2023 had 73116 (cleaned) words - 600 were utilized for the visualizations.

Top Words:

  1. may - 968 instances
  2. product - 744 instances
  3. company - 678 instances
  4. clinical - 595 instances
  5. stock - 570 instances

See the parsed data used in the visualization here.
View the actual filing on the SEC website here

The Latest